³Ô¹ÏÍøÕ¾

WHO Announces Second Week Of Quality Training

WHO is pleased to announce the second edition of its Week of Quality training program, focusing on In Vitro Diagnostics (IVDs) in 2024. This initiative, organized by the , in the Access to Medicines and Health Products Division (MHP), WHO HQ, builds upon the success of the last year, which covered vaccines, medicines, and IVDs. In 2024, each product stream will benefit from a dedicated week, empowering manufacturers and regulators with the knowledge and skills needed for quality assurance:

  • Week of Quality for In Vitro Diagnostics (IVDs): April 15-18, 2024
  • Week of Quality for Medicines: May 13-16, 2024
  • Week of Quality for Vaccines & Biotherapeutics: June 10-13, 2024

A Look at the Week of Quality for IVDs in April 2024

The Week of Quality for IVDs 2024 with the theme Optimising IVD product development: principles of design, quality and compliance is specifically designed to equip manufacturers and regulatory authorities in low- and middle-income countries (LMICs) with the essential knowledge and guidance needed to promote strategies for product design, development, and production of IVDs.

This virtual training takes place from 15 to 18 April 2024, from 12:00 to 14:30 (Geneva Time – CEST). Over four virtual training sessions, participants will delve into the fundamentals needed for IVD development and production, including:

  • Core elements of compliant performance evaluation
  • Building ‘quality by design’ into clinical performance studies
  • Usability: a critical step towards true quality
  • IVD software excellence: streamlining validation & verification
  • Improving the quality of instructions for use: content, process, and tools
  • Enhancing quality, safety, and efficacy in the production of IVD analysers
  • Leveraging post-market surveillance data for product quality improvement
  • Increasing the likelihood of attaining “quality-assured” status for IVDs

Join us for the WHO’s Week of Quality for IVDs training program. Register your interest to participate in this valuable training program. IVD manufacturers and regulatory authorities (Ministry of Health, ³Ô¹ÏÍøÕ¾ Regulatory Authorities) in LMICs are welcome to attend. Secure your spot by registering your interest . Don’t miss out!

Registration deadline: April 9, 2024

/Public Release. View in full .